Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 49 , ISSUE 2 ( April-June, 2015 ) > List of Articles

CASE REPORT

Coexistent Tuberculosis of Spine and Chronic Myeloid Leukemia: Resolving the Diagnostic Dilemma and Management

Arvind Jayaswal, Sanjay Yadav, Ankur Goswami, G Vijayraghavan

Citation Information : Jayaswal A, Yadav S, Goswami A, Vijayraghavan G. Coexistent Tuberculosis of Spine and Chronic Myeloid Leukemia: Resolving the Diagnostic Dilemma and Management. J Postgrad Med Edu Res 2015; 49 (2):85-87.

DOI: 10.5005/jp-journals-10028-1152

Published Online: 01-03-2017

Copyright Statement:  Copyright © 2015; The Author(s).


Abstract

How to cite this article

Yadav S, Jayaswal A, Vijayraghavan G, Goswami A. Coexistent Tuberculosis of Spine and Chronic Myeloid Leukemia: Resolving the Diagnostic Dilemma and Management. J Postgrad Med Edu Res 2015;49(2):85-87.


PDF Share
  1. The risk of tuberculosis in patients with cancer. Clin Infect Dis 2006;42(11):1592-1595.
  2. Tuberculosis complicating imatinib treatment for chronic myeloid leukemia. Eur Respir J 2009; 33(3):670-672.
  3. Tuberculosis and malignancy. Q J Med 2010;103(7):461-487.
  4. Risk factors for and attributable mortality from tuberculosis in patients with hematologic malignances. Haematologica 2005;90(8): 1110-1115.
  5. Spinal cord compression of dual etiology, multiple myeloma and spinal tuberculosis. Leuk Lymphoma 2002;43(2):427-428.
  6. Causes of misdiagnosis and mistreatment of spinal TB with radiotherapy in non-endemic areas: a pitfall in diagnosis and treatment. Spine 2005;30(11):E300-304.
  7. Differentiation between spinal tumors and infections with magnetic resonance imaging. Spine 1991;16(Suppl 8):334-338.
  8. Problems in distinguishing spinal tuberculosis from neoplasia on MRI. Neuroradiology 1996;38(suppl 1):97-104.
  9. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 2006;56(2):69-83.
  10. Survival of virulent mycobacterium tuberculosis involves preventing apoptosis induced by Bcl-2 upregulation and release resulting from necrosis in J774 macrophages. Microbiol Immunol 2005;49(9): 845-852.
  11. Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells. PLoS Pathog 2007;3(7):e110
  12. Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner. Blood 2005;105(6):2473-2479.
  13. Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells. Blood 2004;103(5):538-544.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.